Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
暂无分享,去创建一个
Makoto Sawada | Mari Yoshida | Kazuhiro Imamura | Mari Yoshida | M. Sawada | Y. Hashizume | T. Nagatsu | Yoshio Hashizume | Toshiharu Nagatsu | Nozomi Hishikawa | N. Hishikawa | K. Imamura | M. Yoshida
[1] D. Walker,et al. Microglia in degenerative neurological disease , 1993, Glia.
[2] Kenji Kosaka,et al. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies , 2001, Journal of the Neurological Sciences.
[3] Hugh Perry,et al. The importance of ion channels for macrophage and microglial activation in vitro , 1998, Glia.
[4] I. Mackenzie. Activated microglia in dementia with Lewy bodies , 2000, Neurology.
[5] H. Ichinose,et al. Cytokines in Parkinson’s Disease , 2000 .
[6] M. Mattson,et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Suzumura,et al. Generation and characterization of monoclonal antibodies against rat microglia and ontogenic distribution of positive cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[8] G. Kreutzberg,et al. Regulation of thrombospondin in the regenerating mouse facial motor nucleus , 1996, Glia.
[9] Kurt Jellinger,et al. Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.
[10] V. Perry. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.
[11] D. Selkoe,et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.
[12] R. Mohney,et al. Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.
[13] E. Hirsch,et al. Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis , 2001, The Journal of Neuroscience.
[14] M. Sakanaka,et al. Neurons Induce the Activation of Microglial Cellsin Vitro , 1998, Experimental Neurology.
[15] S. Styren,et al. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain , 1990, Experimental Neurology.
[16] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[17] T. Moos,et al. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease , 1999, Neuroscience.
[18] D. Maysinger,et al. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: Congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury , 1995, International Journal of Developmental Neuroscience.
[19] D. Dickson,et al. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. , 1990, The American journal of pathology.
[20] T. Molitor,et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.
[21] J. Li,et al. Free radicals in Parkinson's disease , 2002, Journal of Neurology.
[22] Y. Agid,et al. Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.
[23] Expression of HLA-DR and interleukin-2 receptor on reactive microglia in senile dementia of the alzheimer's type , 1987, Journal of Neuroimmunology.
[24] Alexander Sasha Rabchevsky,et al. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth , 1997, Journal of neuroscience research.
[25] E. Hirsch,et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Marunouchi,et al. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells , 1995, International Journal of Developmental Neuroscience.
[27] T. Cai,et al. Energetics of Leukocyte Integrin Activation (*) , 1995, The Journal of Biological Chemistry.
[28] P. Mcgeer,et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR , 1987, Neuroscience Letters.
[29] J. Houlé,et al. Activated Macrophage/Microglial Cells Can Promote the Regeneration of Sensory Axons into the Injured Spinal Cord , 1997, Experimental Neurology.
[30] D. Dickson,et al. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[31] K. Beyreuther,et al. A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.
[32] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[33] K. Jellinger. Cell death mechanisms in Parkinson's disease , 2000, Journal of Neural Transmission.
[34] S. Appel,et al. Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.
[35] G. Kreutzberg,et al. Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration , 1998, Journal of neurocytology.
[36] M. Schwartz,et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] I. Tooyama,et al. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders , 2004, Acta Neuropathologica.
[38] M. Mattson,et al. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.
[39] P. Blumbergs,et al. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. , 1995, Brain : a journal of neurology.
[40] M. Farooque,et al. Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats. , 1999, Journal of neurotrauma.
[41] M. Sakanaka,et al. Microglial cells prevent nitric oxide‐induced neuronal apoptosis in vitro , 1998, Journal of neuroscience research.
[42] A. Bruce-Keller. Microglial–neuronal interactions in synaptic damage and recovery , 1999, Journal of neuroscience research.
[43] S. Styren,et al. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.
[44] L. Haverkamp,et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain , 1995, Neurochemistry International.
[45] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[46] P. Carvey,et al. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. , 2001, Experimental neurology.
[47] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[48] K. Nagata,et al. Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro. , 1993, Brain research. Developmental brain research.
[49] Bin Liu,et al. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. , 2000, The Journal of pharmacology and experimental therapeutics.
[50] J. Naegele,et al. Activation of Microglia during Developmentally Regulated Cell Death in the Cerebral Cortex , 2000, Developmental Neuroscience.
[51] V. Perry,et al. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain , 1985, Neuroscience.
[52] Geoffrey A. Donnan,et al. Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.
[53] G. Kreutzberg,et al. Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages , 1990, Journal of neuroscience research.
[54] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[55] P. Mcgeer,et al. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease , 2004, Acta Neuropathologica.
[56] P. Carvey,et al. Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons , 2001, Experimental Neurology.